BioLineRx Ltd (BLRX)

[midastouch017]

BioLineRx to Report Second Quarter 2020 Results on August 6, 2020

Fri July 31, 2020 7:00 AM|PR Newswire|About: BLRX

TEL AVIV, Israel, July 31, 2020 /PRNewswire/ -- BioLineRx Ltd. (BLRX) (TASE: BLRX), a late clinical-stage biopharmaceutical company focused on oncology, announced today it will release its unaudited financial results for the quarter ended June 30, 2020 on Thursday, August 6, 2020, before the US markets open.

The Company will host a conference call on Thursday, August 6, 2020 at 10:00 a.m. EDT featuring remarks by Philip Serlin, Chief Executive Officer. The conference call will be available via webcast and can be accessed through the Investor Relations page of BioLineRx's website. Please allow extra time prior to the call to visit the site and download any necessary software to listen to the live broadcast.

To dial into the conference call, please dial [phone] from the U.S. or [phone] internationally. A replay of the conference call will be available approximately two hours after completion of the live conference call on the Investor Relations page of BioLineRx's website. A dial-in replay of the call will be available until August 8, 2020; please dial [phone] from the U.S. or [phone] internationally.